Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: Extensive similarity except for a difference at chromosome 2q24-q32

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2715-2719

  Tapper, Johanna ^a   Sarantaus, Laura ^a   Vahteristo, Pia ^a   Nevanlinna, Heli ^a   Hemmer, Samuli ^a   Seppälä, Markku ^a   Knuutila, Sakari ^b   Butzow, Ralf ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 2Q; CHROMOSOME 8P; CHROMOSOME LOSS; CHROMOSOME MAP; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DNA HYBRIDIZATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0032127379     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Boyd, J., and Rubin, S. C. Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecol. Oncol., 64: 196-206, 1997.
2. Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., McTieman, A., Offit, K., Perlman, J., Petersen, G., Thomson, E., and Varricchio, C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. J. Am. Med. Assoc., 277: 997-1003, 1997.
3. Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., Love, R., Evans, G., Easton, D., Clayton, D., Stratton, M. R., and Ponder, B. A. J. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat. Genet., 11: 428-433, 1995.
4. Gayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B. A., Stratton, M. R., and Easton, D. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat. Genet., 15: 103-105, 1997.
5. Tapper, J., Butzow, R., Wahlstrom, T., Seppälä, M., and Knuutila, S. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas. Br. J. Cancer, 75: 1782-1787, 1997.
6. Bewtra, C., Watson, P., Conway, T., Read, H. C., and Lynch, H. T. Hereditary ovarian cancer: a clinicopathological study. Int. J. Gynecol. Pathol., 11: 180-187, 1992.
7. Auranen, A., Grenman, S., and Klemi, P. J. Immunohistochemically detected p53 and HER-2/neu expression and nuclear DNA content in familial epithelial ovarian carcinomas. Cancer (Phila.), 79: 2147-2153, 1997.
8. Rubin, S. C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., Lynch, H. T., and Boyd, J. Clinical and pathological features of ovarian cancer in women with germ-line mutations of. BRCA1. N. Engl. J. Med., 335: 1413-1416, 1996.
9. Kallioniemi, A., Kallioniemi, O-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
10. Vehmanen, P., Friedman, L. S., Eerola, H., Sarantaus, L., Pyrhonen, S., Ponder, B. A., Muhonen, T., and Nevanlinna, H. A low proportion of BRCA2 mutations in Finnish breast cancer families. Am. J. Hum. Genet., 60: 1050-1058, 1997.
11. Vehmanen, P., Friedman, L. S., Eerola, H., McClure, M., Ward, B., Sarantaus, L., Kainu, T., Syrjakoski, K., Pyrhonen, S., Kallioniemi, O-P., Muhonen, T., Frank, T. S., and Nevanlinna, H. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum. Mol. Genet., 6: 2309-2315, 1997.
12. El Rifai, W., Larramendy, M. L., Bjorkqvist, A-M., Hemmer, S., and Knuutila, S. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab. Invest., 77: 699-700, 1998.
13. Kuukasjarvi, T., Tanner, M., Pennanen, S., Karhu, R., Visakorpi, T., and Isola, J. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer, 18: 94-101, 1997.
14. Larramendy, M. L., El Rifai, W., and Knuutila, S. Comparison of fluorescein isothiocyanate- and Texas Red-conjugated nucleotides for direct labeling in comparative genomic hybridization. Cytometry, 31: 174-179, 1998.
15. Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Hailing, K. C., Keeney, G., Podratz, K. C., and Jenkins, R. B. Human epithelial ovarian cancer allelotype. Cancer Res., 53: 2393-2398, 1993.
16. Dodson, M. K., Hartmann, L. C., Cliby, W. A., DeLacey, K. A., Keeney, G. L., Ritland, S. R., Su, J. Q., Podratz, K. C., and Jenkins, R. B. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res., 53: 4456-4460, 1993.
17. Pejovic, T., Heim, S., Mandahl, N., Baldetorp, B., Elmfors, B., Floderus, U-M., Furgyik, S., Helm, G., Himmelmann, A., Willen, H., and Mitelman, F. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer, 4: 58-68, 1992.
18. Iwabuchi, H., Sakamoto, M., Sakunaga, H., Ma, Y. Y., Carcangiu, M. L., Pinkel, D., Yang, F. T., and Gray, J. W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res., 55: 6172-6180, 1995.
19. Arnold, N., Hägele, L., Walz, L., Schempp, W., Pfisterer, J., Bauknecht, T., and Kiechle, M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer, 16: 46-54, 1996.
20. Tirkkonen, M., Johannsson, O., Agnarsson, B. A., Olsson, H., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J., Barkardottir, R. B., Borg, A., and Kallioniemi, O-P. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57: 1222-1227, 1997.
21. Pere, H., Tapper, J., Wahlstrom, T., Knuutila, S., and Butzow, R. Distinct chromosomal imbalances in uterine serous and endometrioid carcinomas. Cancer Res., 58: 892-895, 1998.
22. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
23. Vocke, C. D., Pozzatti, R. O., Bostwick, D. G., Florence, C. D., Jennings, S. B., Strup, S. E., Duray, P. H., Liotta, L. A., Emmert-Buck, M. R., and Linehan, W. M. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res., 56: 2411-2416, 1996.
24. Seitz, S., Rohde, K., Bender, E., Nothnagel, A., Kolble, K., Schlag, P. M., and Scherneck, S. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families. Oncogene, 14: 741-743, 1997.
25. ten Dijke, P., Ichijo, H., Franzen, P., Schulz, P., Saras, J., Toyoshima, H., Heldin, C. H., and Miyazono, K. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene, 8: 2879-2887, 1993.
26. Rothe, M., Xiong, J., Shu, H. B., Williamson, K., Goddard, A., and Goeddel, D. V. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc. Natl. Acad. Sci. USA, 93: 8241-8246, 1996.
27. Leyns, L., Bouwmeester, T., Kim, S. H., Piccolo, S., and De, R. E. Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell, 88: 747-756, 1997.
28. Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M. C., Hwang, L. Y., Bowcock, A. M., and Baer, R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet., 14: 430-440, 1996.